Prognostic Value of Delta LUS Score of Patients Hospitalized for Acute Heart Failure
Deltalus
1 other identifier
observational
500
1 country
2
Brief Summary
prognostic value of delta LUS score of patients hospitalized for acute heart failure within 30 days of discharge.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2023
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 17, 2023
CompletedStudy Start
First participant enrolled
March 30, 2023
CompletedFirst Posted
Study publicly available on registry
May 23, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2023
CompletedMay 23, 2023
May 1, 2023
9 months
March 17, 2023
May 13, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Delta lus
The primary outcome evaluate the contribution of the variation of the LUS score performed at the time of admission (LUS1) and at discharge (LUS2) in predicting the clinical course of patients admitted for acute cardiac
30 days
Readmission
Readmission
30 days
Eligibility Criteria
This is a prospective observational study that will be conducted in the emergency department of CHU Fattouma Bourguiba Monastir over a period from March 2023 to December 2023. Will be included in this study patients aged over 18 years, hospitalized in the emergency department for dyspnea having as etiology an acute heart failure and in whom will be performed two pulmonary ultrasound examinations (at entry and exit). These patients will be contacted after one month of their discharge from the hospital
You may qualify if:
- Patients aged over 18 years,
- Patients hospitalized in the emergency department for dyspnea having as etiology an acute heart failure and in whom will be performed two pulmonary ultrasound examinations (at entry and exit).
You may not qualify if:
- Age less than 18 years
- Dyspnea of non-cardiac etiology (cause: pulmonary, traumatic, toxic...)
- Altered state of consciousness (Glasgow score\<14)
- Hemodynamic instability: presence of peripheral signs of shock, use of vasoactive drugs
- Mechanical ventilation from the outset
- Cardiorespiratory arrest
- Inability to give consent to the study
- Missing one of two ultrasound examinations
- Unable to make telephone contact after one month.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Semir Nouira
Monastir, Monastur, 5000, Tunisia
Emergency Departement
Monastir, 5000, Tunisia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nouira Semir, Pr
University of Monastir
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 10 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- clinical proffesor
Study Record Dates
First Submitted
March 17, 2023
First Posted
May 23, 2023
Study Start
March 30, 2023
Primary Completion
December 30, 2023
Study Completion
December 30, 2023
Last Updated
May 23, 2023
Record last verified: 2023-05